The latest updates in the Biotechnology Industry.

Katherine Tai
POSTED ON
March 19, 2021

Here is a look at how the Biden administration’s agriculture policy agenda will impact the biotechnology sector and members of BIO.

POSTED ON
February 25, 2021
Mapillar Dahn has three daughters—and they all have sickle cell disease. But she gained hope thanks to Global Blood Therapeutics (GBT) drug Oxbryta, the first FDA-approved drug targeting the underlying cause of sickle cell disease rather than just its symptoms. Dahn’s oldest daughter, Tully, was…
Ted Love
Connor McKoy
Food & Farm Innovation
Sustainable Fuels
Karen Batra
Sustainable Fuels
Bio-based Manufacturing
Theresa Brady
Events
Patient & Health Advocacy Summit
Vicky Stinson
Health
Policy